![Michael Henderson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 97 M $ al 31/05/2026
Michael Henderson fundó PellePharm, Inc. Es director general de QED Therapeutics, Inc., director general de Origin Biosciences, Inc. y director comercial de BridgeBio Pharma, Inc. y forma parte del consejo de administración de otras cinco empresas. En el pasado ocupó el cargo de Asociado Senior en McKinsey & Co. El Dr. Henderson se licenció en la Universidad de Harvard y se doctoró en la Universidad de Stanford.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 10/06/2026 | 1.095.987 ( 1,96 % ) | 90 M $ | 31/05/2026 | |
| 27/05/2026 | 88.606 ( 0,1 % ) | 7 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| SPYRE THERAPEUTICS, INC. | Director/Miembro de la Junta | 22/06/2023 |
| APOGEE THERAPEUTICS, INC. | Director Ejecutivo | 01/09/2022 |
QED Therapeutics, Inc.
 QED Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Director Ejecutivo | - |
Origin Biosciences, Inc.
 Origin Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Director Ejecutivo | - |
Therasis, Inc.
 Therasis, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology drugs | Director/Miembro de la Junta | 01/09/2016 |
Adrenas Therapeutics, Inc. | Director/Miembro de la Junta | 01/07/2017 |
Quartz Therapeutics, Inc. | Director/Miembro de la Junta | 01/09/2016 |
| Empresas | Cargo | Fin |
|---|---|---|
| ARYA SCIE | Director/Miembro de la Junta | 01/08/2024 |
| BRIDGEBIO PHARMA, INC. | Corporate Officer/Principal | 01/09/2022 |
| ░░░░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 13 |
|---|---|
Spyre Therapeutics, Inc.
 Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
PellePharm, Inc.
 PellePharm, Inc. BiotechnologyHealth Technology Develops biotechnologies to cure dermatological diseases | Health Technology |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Therasis, Inc.
Therasis, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology drugs | Health Technology |
QED Therapeutics, Inc.
QED Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
Origin Biosciences, Inc.
Origin Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
BridgeBio Pharma, Inc.
 BridgeBio Pharma, Inc. BiotechnologyHealth Technology Develops medicines for genetic diseases to patients | Health Technology |
Quartz Therapeutics, Inc. | |
Adrenas Therapeutics, Inc. | |
ARYA Sciences Acquisition Corp. IV
 ARYA Sciences Acquisition Corp. IV Financial ConglomeratesFinance Operates as a blank check company | Finance |
Apogee Therapeutics, Inc.
 Apogee Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops therapies for immunological and inflammatory disorders | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
